Alzheimer’s Disease: 5 Stocks on Biotech Radars

While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps.

Articles You May Like

Abortion battle shifts to US Congress and midterm elections
How to Find Value Stocks Using the Price to Sales Ratio
Mortgage Layoffs Surge As Rising Rates Crush Lending Activity
Quarter-end buying may lift stocks higher before the next market storm
McKinsey: The Metaverse Could Generate $5 Trillion by 2030 — ‘Simply Too Big to Be Ignored’